Related Experiment Video
Updated: Jun 18, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Bordetella pertussis vaccine strains and circulating isolates in Serbia
Gordana Dakic1, Teemu Kallonen, Annika Elomaa
1Institute of Virology, Vaccine and Sera Torlak, Belgrade, Serbia.
Abstract:
In Serbia, whole cell pertussis vaccine was introduced in 1957. Current composition of the vaccine has been used since 1985 and contains four autochthonous strains of Bordetella pertussis isolated from 1957 to 1984. To monitor changes in bacterial population, 70 isolates collected from 1953 to 2000 were studied together with the vaccine strains. The methods included serotyping of fimbriae (Fim), genotyping of pertactin (prn) and pertussis toxin S1 subunit (ptxA), and pulsed-field gel electrophoresis analysis. Shift from ptxA2 to ptxA1 has been observed in isolates since the late of 1960s. All isolates from 1980 to 1984 harbored ptxA1. Re-appearance of the ptxA2 allele followed an addition of the two strains harboring ptxA1 in the vaccine in 1985. The allele prn1 was predominant among the Serbian isolates, though prn3 and prn11 have been detected since 1981 and 1984. The allele prn2 was found only in two strains isolated in 2000. Serotype Fim2.3 disappeared before 1980 and serotype Fim2 became predominant since then. The Serbian vaccine strains showed differences in ptxA and prn. The results of this present study indicate that the B. pertussis population in Serbia is different from other vaccinated populations and that this difference may be related to the vaccine used.
Insights
Serbian Bordetella pertussis strains show genetic differences from other vaccinated populations. These variations in pertussis toxin (ptxA) and pertactin (prn) alleles may be linked to the specific whole cell pertussis vaccine composition used since 1985.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- Serbia has utilized a whole cell pertussis vaccine since 1957, with its current formulation established in 1985.
- The vaccine contains four autochthonous Bordetella pertussis strains isolated between 1957 and 1984.
Observation:
- A study analyzed 70 Bordetella pertussis isolates (1953-2000) and vaccine strains using serotyping, genotyping (ptxA, prn), and pulsed-field gel electrophoresis.
- Genetic shifts were observed, including a move from ptxA2 to ptxA1 alleles in the late 1960s, with ptxA1 predominant by 1980-1984.
- The re-emergence of ptxA2 followed the 1985 vaccine update introducing ptxA1 strains.
- prn1 was the dominant allele, with prn3 and prn11 appearing later, and prn2 detected only in 2000.
- Fimbrial serotype Fim2.3 vanished before 1980, with Fim2 becoming predominant.
Findings:
- Serbian Bordetella pertussis isolates exhibit distinct genetic profiles compared to those in other vaccinated populations.
- Significant variations were noted in the ptxA and prn alleles between the Serbian vaccine strains and the studied isolates.
- The observed genetic changes in Bordetella pertussis correlate with the vaccine's historical composition and introduction timeline.
Implications:
- The unique genetic characteristics of Serbian Bordetella pertussis strains may necessitate tailored vaccine strategies or monitoring.
- Understanding these population dynamics is crucial for evaluating vaccine effectiveness and guiding future pertussis vaccine development.
- The study highlights the potential impact of vaccine strain selection on the evolution of circulating bacterial populations.
Related Concept Videos
Respiratory Syncytial Virus Disease
Diphtheria
Poliomyelitis
Smallpox
Vaccine Production
Chickenpox

